MLM Companies
USANA Health Sciences Review 2026
Publicly traded nutrition MLM with declining revenue trend
2.4
HomeBusinessWatch Rating
Last updated: March 20, 2026
What is USANA Health Sciences?
Nutritional supplements, diet and energy products, and personal care products sold through a network of Associates. Publicly traded on NYSE (USNA). Revenue declined from $921M (2023) to $855M (2024).
Pros
- Publicly traded (NYSE: USNA) — financial transparency via SEC filings
- Products generally well-regarded for quality and manufacturing standards
- Strong presence in Asia Pacific markets
- No required autoship order — flexible purchase structure
Cons
- Revenue declining — $921M (2023) to $855M (2024), net earnings dropped from $63.8M to $42M
- Binary compensation plan is complex and favors positioning over effort
- Products significantly overpriced vs. comparable retail supplements
- Majority of Associates earn minimal income
- Heavy recruiting emphasis to advance and earn meaningful commissions
Rating Breakdown
Residual Income
2.0
Potential for ongoing passive income
Simplicity
2.0
Easy to understand and execute
Transparency
3.0
Clear about costs, requirements, and income
Community & Support
3.0
Quality of training and community
Value for Money
2.0
Worth the investment
Overall Rating
2.4
Frequently Asked Questions About USANA Health Sciences
Is USANA a good MLM?
USANA has higher quality products than many MLMs and is publicly traded for transparency. However, like most MLMs, the majority of Associates earn little to no income. Revenue has been declining, and the binary compensation plan favors those who join early.
Is USANA publicly traded?
Yes. USANA Health Sciences (USNA) trades on the NYSE. Full-year 2024 results showed net sales of $855 million and net earnings of $42 million — down from $921M and $63.8M respectively in 2023.
What are USANA's best products?
USANA's CellSentials (multivitamin/antioxidant), BiOmega (fish oil), and Active Nutrition products are among their most popular. Products are manufactured to pharmaceutical-grade standards in their own facility.